Next Article in Journal
Abnormalities in Lung Volumes and Airflow in Children with Newly Diagnosed Connective Tissue Disease
Previous Article in Journal
Serum Levels of Apoptosis-Related Markers (sFasL, TNF-α, p53 and bcl-2) in COPD Patients
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Typing Safe Antibiotics in Amoxicillin Hypersensitive Patients—Development of a Stepwise Protocol

by
Krzysztof Specjalski
*,
Karolina Kita-Milczarska
,
Marta Chełmińska
and
Ewa Jassem
Department of Allergology, Medical University of Gdańsk, ul. Dębinki 7, 80-952 Gdańsk, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2016, 84(1), 16-21; https://doi.org/10.5603/PiAP.2016.0001
Submission received: 15 July 2015 / Revised: 19 January 2016 / Accepted: 19 January 2016 / Published: 19 January 2016

Abstract

Introduction: A history of an adverse reaction to amoxicillin, irrespective of the mechanism involved, significantly elevates patients’ anxiety and affects therapeutic decisions in the future, leading to unnecessary avoidance of antibiotics. As a consequence, it would be useful to find a safe and reliable protocol for typing safe alternative antibiotics. The aim of the study was to determine negative predictive value of typing safe antibiotic in patients with a history of hypersensitivity reaction to amoxicillin. Material and methods: 71 patients, aged 20−83, with a history of an adverse reaction to amoxicillin were retrospectively analysed. On the basis of the reaction type they were divided into three groups: A—symptoms not typical for hypersensitivity reactions, B—allergy manifested by urticaria and/or angioedema, C—anaphylaxis. In group A amoxicillin was tested, in group B—cefuroxime, and in group C—macrolide: azithromycin or clarithromycin. Telephone follow-up visits were performed twice: 6−12 months and 3−5 years after the clinical assessment to evaluate tolerance of antibiotics. On the basis of the follow-up results, the negative predictive value (NPV) of the protocol was calculated. Results: The full diagnostic protocol was applied in 62 participants. Amoxicillin was found safe in 22, cefuroxime—in 21 and macrolide—in 19 patients. No anaphylactic reactions were observed during the tests. On the basis of the telephone follow-up, the NPV of the protocol was 96% in the first follow-up and 97% in the second one. Conclusion: A stepwise approach including SPTs, ICTs and provocations with amoxicillin / cefuroxime/macrolide—depending on a patient’s history—is safe and allows typing an antibiotic in the vast majority of patients.
Keywords: beta-lactam allergy; drug allergy management; drug challenge test; skin tests; drug typing beta-lactam allergy; drug allergy management; drug challenge test; skin tests; drug typing

Share and Cite

MDPI and ACS Style

Specjalski, K.; Kita-Milczarska, K.; Chełmińska, M.; Jassem, E. Typing Safe Antibiotics in Amoxicillin Hypersensitive Patients—Development of a Stepwise Protocol. Adv. Respir. Med. 2016, 84, 16-21. https://doi.org/10.5603/PiAP.2016.0001

AMA Style

Specjalski K, Kita-Milczarska K, Chełmińska M, Jassem E. Typing Safe Antibiotics in Amoxicillin Hypersensitive Patients—Development of a Stepwise Protocol. Advances in Respiratory Medicine. 2016; 84(1):16-21. https://doi.org/10.5603/PiAP.2016.0001

Chicago/Turabian Style

Specjalski, Krzysztof, Karolina Kita-Milczarska, Marta Chełmińska, and Ewa Jassem. 2016. "Typing Safe Antibiotics in Amoxicillin Hypersensitive Patients—Development of a Stepwise Protocol" Advances in Respiratory Medicine 84, no. 1: 16-21. https://doi.org/10.5603/PiAP.2016.0001

Article Metrics

Back to TopTop